Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity

Tumor vaccines are an important asset in the field of cancer immunotherapy. Whether prophylactic or therapeutic, these vaccines aim to enhance the T cell-mediated anti-tumor immune response that is orchestrated by dendritic cells. Although promising preclinical and early-stage clinical results have...

Descripción completa

Detalles Bibliográficos
Autores principales: Fennemann, Felix L., de Vries, I. Jolanda M., Figdor, Carl G., Verdoes, Martijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476980/
https://www.ncbi.nlm.nih.gov/pubmed/31040852
http://dx.doi.org/10.3389/fimmu.2019.00824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476980/
https://www.ncbi.nlm.nih.gov/pubmed/31040852
http://dx.doi.org/10.3389/fimmu.2019.00824

Ejemplares similares